Atom | Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01

Funder: National Institutes of Health (NIH)

Due Dates: October 4, 2023 (New applications)

Funding Amounts: Up to $500,000 direct costs per year for up to 5 years; total budget up to $3.75M/year for up to 5 awards

Summary: Supports mechanistic research on TDP-43 proteinopathies, including LATE, FTD, and other ADRDs, focusing on causal relationships and overlapping mechanisms.

Key Information: Clinical trials are not allowed; applications must compare at least two TDP-43 proteinopathies, one being an ADRD; mechanistic studies only; diverse populations encouraged.

Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed)

Sign in to see full grant listing